30
/de/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
Public Timelines
FAQ
Menu
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Open cabinet
Erstellen
Close
Create a timeline
Public timelines
Library
FAQ
Herunterladen
Export
Eine Kopie erstellen
Premium
In der Webseite integrieren
asdfg
Editieren
Wurde aktualisiert 16 Okt 2017
0
0
308
Share
Autoren
Created by
Daniel Rossi
List of Edits
Attachments
Comments
Ereignisse
Founded as Genetix Pharmaceuticals
Jesse Gelsinger Dies, Interest Lost in Gene Therapy
Series A Financing, $20 million raised
Phase I/II Beta Thallassemia trial launched
Genetix Launches ADL Program
Series B, $35 million raised, new CEO from Third Rock Ventures
Series C, $35 million
Series D, $60 million
Initial Public Offering, $116 million
Cash assets expected to run out
Phase 3 End Date, Beta Thalassemia
Phase 2/3 end date, ALD
About & Feedback
Vereinbarung
Privatheit
Bibliothek
2024
©
Time.Graphics
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews
Write your own review on
Trustpilot.com
Comments